SNCA - Stem-Cell Based Therapy for Alzheimers Disease

Alzheimer’s disease (AD) is the most common cause of dementia, a progressively debilitating neurodegenerative disease that results in declining cognitive functions, inability to form new memories, behavioral disorders, and gradual loss of bodily functions. While older age does not cause AD, the risk of AD doubles about every five years beyond age 651. The World Health Organization estimates that about 50 million people living with dementia globally. In 2050, the number is expected to increase to 152 million2. In the U.S., a total of 122,019 recorded deaths were due to AD (2018), making it the 6th leading cause of death among adults in the country3. Hence, AD has a significant disease burden worldwide. Currently, the economic burden of AD is estimated to be $305 billion4. To date, there is no cure for dementia or AD. Read More >>